Henry Schein, Inc. (NASDAQ:HSIC) has received a consensus rating of “Hold” from the seventeen ratings firms that are currently covering the stock, MarketBeat reports. Eleven research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $182.08.

Several equities analysts have recently issued reports on the stock. Barrington Research upped their price objective on shares of Henry Schein from $196.00 to $198.00 and gave the company an “outperform” rating in a report on Wednesday, May 10th. Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $204.00 price objective on the stock in a report on Thursday, May 25th. Credit Suisse Group restated a “hold” rating and set a $160.00 price objective on shares of Henry Schein in a report on Thursday, July 13th. Craig Hallum initiated coverage on shares of Henry Schein in a report on Tuesday, April 11th. They set a “hold” rating on the stock. Finally, Stifel Nicolaus upped their target price on Henry Schein from $174.00 to $178.00 and gave the company a “hold” rating in a research report on Wednesday, May 10th.

Shares of Henry Schein (NASDAQ HSIC) opened at 182.83 on Friday. The stock has a market cap of $14.50 billion, a P/E ratio of 27.79 and a beta of 1.09. The stock’s 50 day moving average is $183.66 and its 200-day moving average is $173.71. Henry Schein has a one year low of $146.23 and a one year high of $186.99.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, May 9th. The company reported $1.76 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.65 by $0.11. Henry Schein had a net margin of 4.53% and a return on equity of 19.74%. The firm had revenue of $2.92 billion for the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter in the prior year, the company posted $1.41 earnings per share. The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. On average, equities analysts forecast that Henry Schein will post $7.28 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Henry Schein, Inc. (HSIC) Receives Average Rating of “Hold” from Analysts” was published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2017/07/28/henry-schein-inc-hsic-receives-average-rating-of-hold-from-analysts.html.

In other news, EVP Gerald A. Benjamin sold 12,578 shares of the stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $175.10, for a total transaction of $2,202,407.80. Following the transaction, the executive vice president now owns 44,061 shares in the company, valued at approximately $7,715,081.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.27% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in HSIC. Thrivent Financial for Lutherans increased its position in Henry Schein by 4.9% in the fourth quarter. Thrivent Financial for Lutherans now owns 2,810 shares of the company’s stock valued at $426,000 after buying an additional 130 shares in the last quarter. Quadrature Capital Ltd bought a new stake in shares of Henry Schein during the fourth quarter worth about $1,140,000. Kentucky Retirement Systems bought a new stake in shares of Henry Schein during the fourth quarter worth about $886,000. Kentucky Retirement Systems Insurance Trust Fund bought a new stake in shares of Henry Schein during the fourth quarter worth about $395,000. Finally, Macquarie Group Ltd. increased its stake in shares of Henry Schein by 84.0% in the fourth quarter. Macquarie Group Ltd. now owns 4,600 shares of the company’s stock worth $698,000 after buying an additional 2,100 shares during the period. Hedge funds and other institutional investors own 90.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.